Fas Ligand Induction in Human NK Cells Is Regulated by Redox Through a Calcineurin-Nuclear Factors of Activated T Cell-Dependent Pathway

Keizo Furuke, Mitsuhiro Shiraishi, Howard S. Mostowski and Eda T. Bloom
J Immunol February 15, 1999, 162 (4) 1988-1993;

Abstract

Fas ligand (FasL) on cytotoxic lymphocytes is important for mediating apoptosis of activated lymphocytes and other target cells. We have reported that NK cell functions, such as proliferation, cell death, and killing activity, are subject to regulation by cellular redox status. Here, we report that expression of FasL protein and mRNA in activated NK cells is also regulated by redox. Ligation of CD16 on IL-2-preactivated NK cells resulted in reduction of intracellular peroxide level as well as induction of FasL expression. This CD16-induced FasL expression was suppressed by oxidative stress, including thiol deprivation or treatment with hydrogen peroxide (H2O2). Addition of thiol-reducing compounds, such as l-cystine, 2-ME, or N-acetyl cysteine, restored FasL expression. These data suggest that CD16 stimulation requires cellular reducing status for FasL induction in NK cells. Because FasL gene activation following CD16 cross-linking is regulated by the NF of activated T cells (NFAT), we examined the effect of oxidative stresses on NFAT activation. Electrophoretic mobility shift assays revealed that both thiol insufficiency and H2O2 treatment suppressed DNA-binding activity of NFAT and that addition of thiol-reducing compounds reversed or even enhanced it. Furthermore, these oxidative stresses inhibited activity of calcineurin, a serine/threonine phosphatase that regulates NFAT activation. These results suggest that suppression of calcineurin and NFAT activation is a mechanism by which oxidative stress inhibits FasL induction in activated NK cells and further support the hypothesis that thiol-reducing compounds might be required for maintenance of optimal NK functions under physiologic oxidative conditions.

Fas (APO-1/CD95) is a surface receptor that transduces a death signal in a variety of cell types upon binding with its natural ligand, Fas ligand (FasL),2 or cross-linking with anti-Fas IgM mAb 1, 2 . CTL and NK cells are known to express FasL during activation and exert granule-independent cytotoxicity via Fas/FasL interaction 1, 2 . In addition, growing evidence shows that cytotoxic lymphocytes treated with anti-CD3 mAb for T cells undergo apoptosis following homotypic interaction through Fas and FasL 3, 4, 5 . NK cells activated with cytokines such as IL-2 exhibit induction of FasL and increased levels of Fas on their cell surface and undergo apoptosis by homotypic interaction upon cross-linking of CD16 (FcγRIII) 6 . Thus, the Fas/FasL system is also considered to play a role for the control of activated cell populations in the immune system.

A number of signaling events mediating FasL gene activation have been investigated. ZAP-70 tyrosine kinase and CD45 tyrosine phosphatase have been reported to be required for TCR-mediated FasL induction in T cells 7, 8 . Induction of FasL expression is suppressed by cyclosporin A (CsA) 9 , glucocorticoid hormone, or retinoic acid 10 . Transcription factors, such as NF of activated T cells (NFAT) and NF-κB, have been reported to be involved in FasL expression in activated T cells 8, 11, 12 . Although both tyrosine phosphorylation and activity of transcriptional factors are known to be subject to regulation by cellular redox status 13, 14 , it is not known whether cellular redox is involved in regulating FasL expression.

We have shown that NK cells cultured in thiol-deficient conditions, which produces decreased levels of reduced glutathione, are unable to respond to IL-2 with increased proliferation and cytotoxicity 15, 16 and that thiol deprivation also facilitates Fas-mediated cell death in NK cells 17 . These findings prompted us to examine the effect of cellular redox status on FasL induction in NK cells treated with IL-2 and/or anti-CD16 mAb and to further identify an underlying mechanism.

Materials and Methods

Reagents and Abs

Human rIL-2 was provided by Amgen (Thousand Oaks, CA). Metalloproteinase inhibitor KB8301 was purchased from PharMingen (San Diego, CA). Anti-CD5 mAb was purified from ascites as previously described 15 . Anti-CD22 mAb was purchased from PharMingen. Anti-CD16 (clone 3G8), anti-CD36, anti-CD56-phycoerythrin (PE), anti-CD16-PE, and anti-CD14-PE mAbs were purchased from Immunotech (Westbrook, ME). Anti-CD16-FITC mAb and anti-CD56 mAb as an isotype control for 3G8 were purchased from Becton Dickinson (Mountain View, CA). Hydrogen peroxide (H2O2), 2-ME, N-acetyl cysteine (NAC), l-cystine (l-Cys), cyclosporin A (CsA), and goat anti-mouse IgG (GaM) mAb were purchased from Sigma (St. Louis, MO).

Cell culture and isolation

Standard RPMI 1640 medium (Life Technologies, Grand Island, NY) contained 10% FCS (HyClone Laboratories, Logan, UT), 50 μg/ml of gentamicin sulfate, and 2 mM glutamine. RPMI 1640 medium without l-Cys and reduced type glutathione (CYS(−) medium) was obtained from KEMP Biotechnologies (Gaithersburg, MD). FCS for CYS(−) medium was dialyzed against PBS to remove small m.w. compounds, including thiols. CYS(+) medium was CYS(−) supplemented with 200 μM l-Cys, the concentration normally found in cell culture medium. Cells were cultured for 12 h in CYS(−) or CYS(+) medium with the indicated FCS and IL-2 supplementation before use to decrease intracellular thiol levels. Total amounts of protein and mRNA, as well as cell viability (>90%), did not differ significantly between purified NK cells cultured for 12 h in CYS(−) or CYS(+) medium.

Human NK cells were purified from buffy coats from healthy donors (Blood Bank, National Institutes of Health, Bethesda, MD) as described 17 . In brief, mononuclear cells were obtained by centrifugation over lymphocyte separation medium (Oreganon Teknika, Durham, NC) and treated with 100 mg/108 cells of sterilized carbonyl iron (Sigma) in standard RPMI 1640 medium at 37°C for 30 min followed by exposure to a magnetic field to remove monocytes. Cell suspensions were centrifuged over 47.5% Percoll to obtain low-density large granular cells. NK-enriched mononuclear cells were further treated with anti-CD5, anti-CD22, and anti-CD36 mAbs at 4°C for 2–4 h, incubated with GaM-coated magnet beads (PerSeptive Biosystems, Framingham, MA) at 4°C for 30 min and exposed to a magnetic field to eliminate residual T cells, B cells, and monocytes. The purity of NK cells (CD16+ and/or CD56+) in each experiment was always 85–95% as assessed by FACScan (Becton Dickinson). The population of contaminating T cells (CD56−, CD3+), B cells (CD20+), or monocytes/macrophages (CD14+) in each experiment was <10%, <5%, or <5%, respectively.

Flow cytometric analysis of expression of FasL and intracellular peroxide levels

Quantitation of surface FasL expression was assessed by flow cytometric analysis. Cells were treated for 6 h with 10 μM KB8301 (PharMingen), a metalloprotease inhibitor, to inhibit FasL release 18 , washed with FACS buffer (PBS with 1% FCS and 0.1% NaN3), and incubated with biotin-conjugated anti-human FasL mAb (PharMingen) or biotin-conjugated mouse IgG1 (PharMingen) for 20 min on ice. After washing with FACS buffer, cells were incubated with streptavidin PE (Becton Dickinson) for 20 min on ice. The fluorescence intensity was measured by FACScan.

Intracellular peroxide levels were assayed as described 19 . Briefly, cells were cultured in medium with 5 μM 2′,7′-dichlorofluorescin diacetate (DCFH-DA; Molecular Probes, Eugene, OR) for 15 min at 37°C following the indicated treatments and harvested for flow cytometry. In experiments designed to confirm whether NK cells contain intracellular peroxides, cells were stained first with anti-CD56- and anti-CD16-PE mAbs to identify NK cells, or with CD14-PE mAb to identify monocyte/macrophages before assay for peroxides with DCFH-DA.

RT-PCR analysis of FasL and IFN-γ mRNA

FasL and IFN-γ mRNA expression was determined by RT-PCR using [32P]dCTP as previously described 17, 20 . Total RNA was isolated from cells using TRIzol (Life Technologies) according to the manufacturer’s instructions. The sequences of the primer pairs in this experiment were as follows: human glyceraldehyde-3-phosphate dehydrogenase (G3PDH; used as an internal control), 5′-GCT CAG ACA CCA TGG GGA AGG T-3′, 5′-GTG GTG CAG GAG GCA TTG CTG A-3′; human FasL, 5′-GTG CCC AGA AGG CCT GGT CAA AGG-3′, 5′-TTG CAA GAT TGA CCC CGG AAG TAT-3′; and human IFN-γ, 5′-GGA CCC ATA TGT AAA AGA AGC AGA-3′, 5′-TGT CAC TCT CCT CTT TCC AAT TCT-3′. Amplifications were performed in a thermocycler (GeneAmp PCR system 9600; Perkin-Elmer, Norwalk, CT) as follows: 94°C, 3 min, followed by 21 (G3PDH) or 35 (FasL and IFN-γ) cycles (94°C, 1 min; 57°C, 1.5 min; 72°C, 2 min). Aliquots of each amplification were analyzed by electrophoresis in 5% acrylamide-Tris-borate gels. The lanes were normalized to G3PDH mRNA levels as described 20 .

Electrophoretic mobility shift assay (EMSA)

Nuclear extracts were prepared as described by Schreiber et al. 21 from cells cultured after the indicated treatment.

The sequence for the human IL-2 distal NFAT site (GGA GGA AAA ACT GTT TCA TAC AGA AGG 22) was used as a probe to measure NFAT activity. dsDNA probe was synthesized in the Center for Biologics Evaluation and Research Core Facility Services (CBER, Food and Drug Administration, Bethesda, MD). The dsDNA probe was end-labeled with [γ32P]ATP (3000 Ci/mmol; Amersham Pharmacia Biotech, Uppsala, Sweden) and T4 polynucleotide kinase (Amersham Pharmacia Biotech) according to the manufacturer’s instructions.

EMSA was performed as described 23 with some modifications. In brief, nuclear extracts (5 μg per reaction volume) were incubated for 20 min at room temperature with 1 μg poly(dI-dC) (Amersham Pharmacia Biotech) and 0.5 ng 32P-labeled dsDNA probe in 20 μl of binding buffer (10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 30 mM KCl, 5 mM MgCl2, 10% glycerol, and 0.05% Nonidet P-40). The reaction was stopped with 2 μl of 0.1% bromophenol blue, followed by electrophoresis on 5% polyacrylamide gels in 0.25× Tris-buffered EDTA (pH 8.4) under nondenaturing conditions. An unlabeled cold probe (5 ng) was added at the beginning of the reaction as a competitor. For supershift, 1 μl of antisera against murine NFAT1 (Upstate Biotechnology, Lake Placid, NY), which cross-reacts with human NFAT1, was added to nuclear extracts and incubated on ice for 30 min before the binding reaction.

Calcineurin assay

Calcineurin activity was assayed as previously described 24 . Hypotonic lysates from 107 purified NK cells were assessed following the indicated treatments for their ability to dephosphorylate a 32P-serine-labeled 19-amino acid peptide substrate (Sigma) in the presence of okadaic acid (Sigma), a phosphatase type 1 and 2A inhibitor. Reaction mixtures contained 20 μl of lysates, 500 nM okadaic acid, 5 μM 32P-labeled phosphopeptide, and 40 μl of assay buffer containing 20 mM Tris (pH 8.0), 100 mM NaCl, 6 mM MgCl2, 0.1 mM CaCl2, 0.5 mM DTT, 0.1 mg/ml of BSA. After 15 min at 30°C, reactions were terminated by the addition of 0.5 ml 100 mM potassium phosphate buffer (pH 7.0) containing 5% trichloroacetic acid. Free inorganic phosphate was isolated using a Dowex cation-exchange resin (AG50W-X8 100–200 mesh; Bio-Rad, Hercules, CA) and quantitated by scintillation counting. Variation between duplicates was <10%. The number of picomoles of phosphate released was calculated by using the sp. act. (cpm in 300 pmol 32P-labeled phosphopeptide) measured on the day of the assay. The protein content of cell lysates was determined with a Bio-Rad Protein Assay Kit, and calcineurin activity was expressed as picomoles of released 32P per minute per milligram of lysate protein.

Results

Time course of increase in FasL expression in IL-2-preactivated NK cells by anti-CD16 Ab

It has been reported that FasL mRNA can be detected in IL-2-preactivated NK cells within 6 h following treatment with anti-CD16 Ab 6 . Therefore, we first examined the time course of cell surface FasL protein expression, as determined by flow cytometry, on IL-2-preactivated NK cells following ligation of CD16. NK cells cultured with IL-2 for 3 days expressed FasL only weakly (mean fluorescent intensity (MFI) < 10). As shown in Fig. 1⇓, however, FasL expression was increased within 6 h and peaked between 6–24 h following addition of anti-CD16 mAb, although time points of the peak FasL expression varied among cells from individual donors. We confirmed that the fluorescence intensity was specific for FasL using biotin-conjugated mouse IgG1 as a negative control. The induction of FasL was specific for CD16 cross-linking because anti-CD56 mAb, an isotype control for anti-CD16 mAb, did not show any alteration in FasL expression.

FIGURE 1.
FIGURE 1.

Time course of CD16-induced FasL expression in IL-2-pretreated NK cells. Purified NK cells were cultured with 100 U/ml of rIL-2 for 3 days, treated with 10 μg/ml of anti-CD16 or an isotype control anti-CD56 mAb plus 10 μg/ml of GaM for the indicated time periods, and harvested for flow cytometric analysis of FasL expression. Data are expressed as means ± SD of the MFI obtained on NK cells from three different donors.

Ligation of CD16 decreased intracellular peroxide level in IL-2-preactivated NK cells

Intracellular peroxide levels are known to reflect the generation of reactive oxygen species (ROS) 25 and to be increased under conditions of oxidative stress 26 . Therefore, we next measured intracellular peroxide levels as an indicator of whether CD16 ligation affects intracellular redox status in IL-2-preactivated NK cells. We found that intracellular peroxides could be detected in CD56+ and/or CD16+ NK cells, which represented >85% of the cell population, and in CD14+ monocyte/macrophages, representing only 3% of the cell population (Fig. 2⇓A). The amount of intracellular peroxide was strongly reduced following treatment with anti-CD16 mAb (Fig. 2⇓B), although no effect was seen with anti-CD56 mAb of the same isotype as the anti-CD16 mAb (data not shown). Furthermore, either culture in CYS(−) medium for 12 h or treatment with 100 μM H2O2 for 2 h increased contents of intracellular peroxides in IL-2-preactivated NK cells (Fig. 2⇓). These results suggest that ROS production is suppressed or levels are quenched following CD16 cross-linking in NK cells, and that both thiol deprivation and H2O2 treatment result in oxidative stress through increasing intracellular ROS levels.

FIGURE 2.
FIGURE 2.

A, Double staining of purified NK cell population with anti-CD56- and anti-CD16-PE mAbs or with anti-CD14-PE mAb in combination with DCFH-DA assay for peroxides. The data are representative of experiments using cells from three different donors and demonstrate that the populations of CD56+ and/or CD16+ NK cells and CD14+ monocyte/macrophages were both positive for peroxide staining and represent 87% and 3% of the cell populations, respectively. B, Effects of treatment with anti-CD16 mAb or H2O2 or culture in CYS(−) medium on intracellular peroxide levels in IL-2-preactivated NK cells. Purified NK cells were cultured in the presence of 100 U/ml of rIL-2 in CYS(+) medium for 72 h (labeled as CONTROL), cultured in CYS(+) medium for 60 h and in CYS(−) medium for an additional 12 h (labeled as CYS(−)), or cultured in CYS(+) medium for 70 h and treated with 10 μg/ml of anti-CD16 plus 10 μg/ml of GaM (labeled as CD16) or with 100 μM H2O2 (labeled as H2O2) in CYS(+) medium for an additional 2 h. Intracellular peroxide levels measured by flow cytometry were reduced by anti-CD16 mAb treatment but increased by addition of exogenous H2O2 or thiol deprivation. A representative of four independent experiments is presented.

Inhibition of FasL induction in anti-CD16-treated NK cells by H2O2 treatment or by thiol deprivation

To evaluate the effects of oxidative stress on FasL expression, we determined the effect of H2O2 treatment on FasL cell surface expression in anti-CD16-treated NK cells. When IL-2-pretreated NK cells were exposed to 0.1–100 μM H2O2 for 12 h, FasL expression induced by anti-CD16 mAb was reduced in a dose-dependent manner (Fig. 3⇓A). Cell viability was not significantly affected at the same concentrations of H2O2 (data not shown).

FIGURE 3.
FIGURE 3.

Effects of H2O2 treatment (A) or thiol deprivation and addition of thiol reducing compounds (B) on CD16-induced FasL expression. A, IL-2-preactivated NK cells were treated with 10 μg/ml of anti-CD16 plus 10 μg/ml of GaM in the presence or absence of the indicated concentrations of H2O2 for 12 h. B, IL-2-pretreated NK cells were cultured in CYS(+) or CYS(−) medium in the presence or absence of 50 μM 2-ME or 10 mM NAC with 10 μg/ml of anti-CD16 or anti-CD56 mAb plus 10 μg/ml of GaM for 12 h. FasL expression determined by flow cytometry was suppressed by oxidative stress, including thiol deprivation or H2O2 treatment, and restored by addition of thiol-reducing compounds, such as l-Cys, 2-ME, or NAC. Data are MFI ± SD from three different donors.

To clarify whether cellular redox status plays a role in FasL induction following CD16 cross-linking, we next assessed the effects on FasL induction of manipulating cellular redox status in activated NK cells using thiol deprivation with CYS(−) medium or by adding back thiol-reducing compounds. NK cells were treated with IL-2 in standard medium for 60 h, followed by culture in CYS(+) or CYS(−) medium in the presence of anti-CD16 or anti-CD56 mAb for an additional 12 h. As shown in Fig. 3⇑B, FasL induction following ligation of CD16 was completely inhibited in CYS(−) medium. No alteration of FasL expression by CYS(−) was observed in anti-CD56-treated NK cells (data not shown). This decrease in FasL expression was completely reversed by addition to CYS(−) medium of 200 μM l-Cys, 50 μM 2-ME, or 10 mM NAC, which are thiol-reducing compounds that we have shown to increase intracellular reduced type glutathione in NK cells 15 (Fig. 3⇑B).

Taken together, these findings show that oxidative stress may generally suppress FasL induction in activated NK cells and that reducing conditions are necessary for optimal FasL expression.

Suppression of FasL mRNA levels and NFAT transcription factor activity in anti-CD16-treated NK cells by thiol deprivation or H2O2 treatment

We next asked whether FasL mRNA expression was also suppressed by oxidative stress. Semiquantitative RT-PCR revealed that the increase in FasL mRNA following treatment with anti-CD16 mAb was completely suppressed by thiol deprivation or H2O2 treatment (Fig. 4⇓). The diminished FasL mRNA levels induced by thiol deprivation were reversed by the addition of l-Cys, 2-ME, or NAC (Fig. 4⇓). In contrast, the augmentation of IFN-γ mRNA levels induced by CD16 cross-linking was not affected by manipulations of cellular redox status, including thiol deprivation, H2O2 treatment, or addition of 2-ME or NAC (Fig. 4⇓), suggesting that events downstream of CD16 activation are not uniformly subject to regulation by redox.

FIGURE 4.
FIGURE 4.

CD16-induced FasL mRNA expression was suppressed by thiol deprivation or H2O2 treatment and restored by addition of thiol compounds. In contrast, mRNA encoding for IFN-γ was augmented by cross-linking of CD16, but this level was unaffected by manipulation of redox conditions. IL-2-preactivated NK cells were cultured in CYS(+) or CYS(−) medium for 9 h, then treated as indicated (described in Fig. 3⇑) for 3 h. RT-PCR analysis for FasL, IFN-γ, or G3PDH mRNA is depicted and is a representative of three independent experiments. Quantitative presentation (percentage of NFAT DNA-binding activity in each sample compared with the sample treated with anti-CD16 in CYS(+) medium, lane 2) is also shown using data obtained by PhosphorImage (Molecular Dynamics, Sunnyvale, CA) analysis.

Because the transcription factor NFAT has been reported to participate in the regulation of FasL expression in activated T cells 11, 27 , we examined the effect of either thiol deprivation or H2O2 treatment on DNA-binding activity of NFAT in anti-CD16-treated NK cells as determined by EMSA. As shown in Fig. 5⇓, activation of NFAT following ligation of CD16 was inhibited by treatment with H2O2 in a dose dependent manner and completely suppressed by thiol depletion. The suppressed DNA-binding activity of NFAT by thiol deprivation was restored by addition of l-Cys or NAC and even augmented by 2-ME treatment compared with CYS(+), indicating that thiol-reducing compounds are required for optimal activation of NFAT. This result also suggests that oxidative stress inhibits CD16-induced FasL expression at the level of, or upstream to, NFAT activation.

FIGURE 5.
FIGURE 5.

DNA binding activity of NFAT following CD16 cross-linking was suppressed by thiol deprivation or H2O2 treatment and restored by addition of thiol compounds. IL-2-preactivated NK cells were cultured in CYS(+) or CYS(−) medium for 11 h, then treated with the indicated treatments as described in Fig. 3⇑ for 1 h, and harvested for EMSA. Lane 1, treated with control anti-CD56 mAb in CYS(+) medium; lane 2, treated with anti-CD16 mAb in CYS(+) medium; lanes 3 and 4, treated with anti-CD16 mAb in the presence of the indicated doses of H2O2 in CYS(+) medium; lanes 5–7, treated with anti-CD16 mAb in CYS(−) medium in the absence or presence of 2-ME or NAC; lane 8, anti-NFAT Ab was added to the same sample as lane 2; lane 9, cold probe was added to the same sample as lane 2. The data are representative of three independent experiments. Quantitative presentation (percentage of FasL mRNA expression in each sample compared with the sample treated with anti-CD16 in CYS(+) medium, lane 2) is also shown using data obtained by PhosphorImage (Molecular Dynamics) analysis.

Thiol deprivation and addition of H2O2 suppressed calcineurin phosphatase activity in vitro

Activation of NFAT is known to be regulated by a CsA-sensitive, calcium/calmodulin-dependent serine/threonine phosphatase, calcineurin 28 . Therefore, we examined whether oxidative stress affects calcineurin activity in IL-2-preactivated NK cells. Culture in CYS(−) medium for 12 h markedly suppressed calcineurin activity compared with standard medium (Fig. 6⇓A). However, treatment of IL-2-preactivated NK cells with H2O2 had only a marginal effect on calcineurin activity, even with 1 mM H2O2. Because the calcineurin assay reaction mixture contained DTT, we next investigated the effect of incubation with H2O2 in vitro of lysates from IL-2-preactivated NK cells, which had not been treated with H2O2, as a more sensitive means to assess changes in calcineurin activity. As shown in Fig. 6⇓B, calcineurin activity in IL-2-preactivated NK cells was inhibited by H2O2 in a dose-dependent fashion. These results demonstrated that oxidative stress, including thiol deprivation or treatment with H2O2, suppressed calcineurin activity in NK cells in vitro, and thereby suggests that suppression of calcineurin activity is a mechanism by which oxidative stress inhibits NFAT activation and FasL induction following CD16 ligation on NK cells.

FIGURE 6.
FIGURE 6.

Effects of oxidative stress, including thiol deprivation or H2O2 treatment, on calcineurin activity. A, IL-2-preactivated NK cells were cultured in CYS(+) or CYS(−) medium for 11 h, then treated with H2O2 (0.1–1 mM) or CsA (10 μM) as a positive control for 1 h, and harvested for calcineurin assay. Means ± SD among the data from three different donors were shown. The data indicated that thiol deprivation suppressed calcineurin activity in IL-2-preactivated NK cells. B, The indicated concentrations of H2O2 or 10 μM CsA were added to the reaction mixtures with lysates from IL-2-preactivated NK cells, and calcineurin activity was assayed. A representative of three repeated experiments is presented. The results demonstrate that calcineurin activity in lysates from IL-2-preactivated NK cells was inhibited by addition of H2O2 in vitro.

Discussion

The present study demonstrated that FasL expression following CD16 ligation on IL-2-preactivated NK cells was suppressed by thiol deprivation and restored by addition of thiol compounds, suggesting that cellular reducing status is required for FasL induction in CD16-stimulated NK cells. This notion was further supported by the findings that another oxidative stressor, H2O2, also inhibited CD16-induced FasL expression and that intracellular ROS levels were decreased following treatment with anti-CD16 mAb. We further showed that oxidative stress, including thiol deprivation or H2O2 treatment, suppressed events upstream of FasL expression, namely calcineurin and NFAT activation, suggesting that oxidative stress suppressed CD16-induced FasL expression through inhibition of calcineurin/NFAT activation or event(s) upstream thereof.

The regulation of a number of transcriptional factors by cellular redox status is well described 14 . However, this regulation is quite complicated. Although H2O2 is known to be a potent activator of NF-κB 29 , and reductants generally decrease transcriptional activity of p53 14 , thiol-reducing compounds activate AP-1 30, 31 and even increase DNA-binding activity of NF-κB 32 . In terms of NFAT, sublethal levels of oxidative stress have been reported to suppress its transcriptional activity and, thereby, IL-2 mRNA expression in activated T cells 33 . We have recently found that DNA-binding activity of NFAT is modulated by nitric oxide, which is highly reactive with superoxide anion and thiols (Furuke et al., unpublished data). In the current study, we demonstrated that DNA-binding activity of NFAT is suppressed by oxidative stress, such as thiol deficiency or treatment with H2O2, and thiol-reducing compounds reversed it, suggesting that the thiol-mediated reducing condition is required for NFAT activation in CD16-activated NK cells.

Activation of NFAT is well known to be regulated by a serine/threonine phosphatase, calcineurin 28 . Since superoxide dismutase protects calcineurin from inactivation 34 and a thiol reducing enzyme, thioredoxin, inhibits activity of CsA and FK506, inhibitors for calcineurin 35 , we hypothesized that cellular redox status affects calcineurin activity, resulting in regulation of NFAT activity. The evidence that the active site of calcineurin contains Fe and Zn ions 36 , both of which are redox-sensitive, supports this possibility. Our study demonstrated that lysates from thiol-depleted NK cells contained lower calcineurin activity than those from normal NK cells, suggesting that calcineurin activity also requires thiol-mediated reducing conditions. However, calcineurin activity in lysates from H2O2-treated NK cells was not significantly altered. We also demonstrated that thiol deprivation was more potent for increasing intracellular peroxide levels than H2O2 treatment. In the calcineurin assay, sufficient doses of a reducing reagent, DTT (0.5 mM), were required to measure calcineurin activity in vitro. Therefore, it is possible that DTT reversed an H2O2 effect on calcineurin activity during the assay, although it was not sufficient to reverse the effect in cells cultured under conditions of thiol deprivation. To determine whether H2O2 treatment can indeed inhibit calcineurin activity, we performed an experiment in which H2O2 was directly added into the reaction mixture with the lysate from IL-2-preactivated NK cells, and the result showed that H2O2 inhibited calcineurin activity in the lysate in a dose-dependent fashion. Taken together, these findings suggest that oxidative stress, including thiol deprivation or H2O2 treatment, inhibits FasL expression induced in activated NK cells through suppression of activation of calcineurin-NFAT pathway. However, thiol deprivation appears to induce oxidative stress more efficiently than addition of H2O2, since reduced calcineurin activity following thiol deprivation was observed even in the presence of DTT in the reaction.

Recent studies on Fas/FasL interaction have revealed that FasL-induced apoptosis is involved in a number of pathological conditions, including eliminating virus-infected or malignant cells, tumor tolerance from cytotoxic lymphocytes, graft rejection, acute hepatitis, and autoimmune disease 1, 2, 37, 38, 39 . Moreover, since ROS have been implicated in the pathophysiology of these disorders 40 , oxidative stress appears to colocalize with sites of Fas/FasL interaction. Although there have been several reports on the redox regulation in Fas receptor expression 41, 42 and on the involvement of ROS in FasL-induction in T cells activated through TCR-stimulation 43, 44 , this is the first study showing the redox control of FasL expression in NK cell activation and exploring the mechanism of that control. Our results may provide not only means to maintain optimal NK functions but also possible therapeutics for such pathological conditions.

Acknowledgments

We thank Dr. C. Wilson for critical review of the manuscript and Dr. K. Ishii for performing some of the flow cytometric analyses.

Footnotes

  • ↵1 Address correspondence and reprint requests to Dr. Eda T. Bloom, Laboratory of Cellular Immunology (HFM-518), Division of Cellular and Gene Therapies, Center for Biologics Evaluation Research, Food and Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892. E-mail address: bloom{at}cber.fda.gov

  • 2 Abbreviations used in this paper: L, ligand; NFAT, NF of activated T cells; CsA, cyclosporin A; CYS(−), RPMI 1640 medium without cystine and reduced type glutathione; CYS(+), CYS(−) in which l-cystine has been replenished; EMSA, electrophoretic mobility shift assay; GaM, goat anti-mouse IgG; G3PDH, glyceraldehyde-3-phosphate dehydrogenase; MFI, mean fluorescent intensity; NAC, N-acetyl cysteine; PE, phycoerythrin; ROS, reactive oxygen species; DCFH-DA, 2′,7′-dichlorofluorescin diacetate.

  • Received July 21, 1998.
  • Accepted November 3, 1998.

References

  1. ↵
    Lynch, D. H., F. Ramsdell, M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16: 569
    OpenUrlCrossRefPubMed
  2. ↵
    Nagata, S., P. Golstein. 1995. The Fas death factor. Science 267: 1449
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Dhein, J., H. Walczak, C. Bäumier, K.-M. Debatin, P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373: 438
    OpenUrlCrossRefPubMed
  4. ↵
    Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynchi, C. F. Ware, D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441
    OpenUrlCrossRefPubMed
  5. ↵
    Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444
    OpenUrlCrossRefPubMed
  6. ↵
    Eischen, C. M., J. D. Schilling, D. H. Lynch, P. H. Krammer, P. J. Leibson. 1996. Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J. Immunol. 156: 2693
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Eischen, C. M., B. L. Williams, W. Zhang, L. E. Samelson, D. H. Lynch, R. T. Abraham, P. J. Leibson. 1997. ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis. J. Immunol. 159: 1135
    OpenUrlAbstract
  8. ↵
    Latinis, K. M., L. L. Carr, E. J. Peterson, L. A. Norian, S. L. Eliason, G. A. Koretsky. 1997. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158: 4602
    OpenUrlAbstract
  9. ↵
    Brunner, T., N. J. Yoo, D. LaFace, C. F. Ware, D. R. Green. 1996. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. Int. Immunol. 8: 1017
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Yang, Y., S. Minucci, K. Ozato, R. A. Heyman, J. D. Ashwell. 1995. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J. Biol. Chem. 270: 18672
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Latinis, K. M., L. A. Norian, S. L. Eliason, G. A. Koretzky. 1997. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272: 31427
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Matsui, K., S. Omura, H. Cui, S. L. Schauer, G. E. Sonenshein, S.-T. Ju. 1997. Proteasome regulation of Fas ligand cytotoxicity. Eur. J. Immunol. 27: 2269
    OpenUrlCrossRefPubMed
  13. ↵
    Monteiro, H. P., A. Stern. 1996. Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways. Free Radical Biol. Med. 21: 323
    OpenUrlCrossRefPubMed
  14. ↵
    Sun, Y., L. W. Oberley. 1996. Redox regulation of transcriptional activators. Free Radical Biol. Med. 21: 335
    OpenUrlCrossRefPubMed
  15. ↵
    Yamauchi, A., E. T. Bloom. 1993. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells. J. Immunol. 151: 5535
    OpenUrlAbstract
  16. ↵
    Yamauchi, A., E. T. Bloom. 1997. Control of cell cycle progression human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein. Blood 89: 4092
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Furuke, K., E. T. Bloom. 1998. Redox-sensitive events in Fas-induced apoptosis in human natural killer cells include ceramide generation and protein tyrosine dephosphorylation. Int. Immunol. 10: 1261
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Kayagaki, N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, H. Yagita. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182: 1777
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Furuke, K., T. Sasada, Y. Ueda-Taniguchi, A. Yamauchi, T. Inamoto, Y. Yamaoka, H. Masutani, J. Yodoi. 1997. Role of intracellular redox status in apoptosis induction of human T-cell leukemia virus type I-infected lymphocytes by 13-cis-retinoic acid. Cancer Res. 57: 4916
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Burd, P. R., W. C. Thompson, E. E. Max, F. C. Mills. 1995. Activated mast cells secrete interleukin-13. J. Exp. Med. 181: 1373
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Schreiber, E., P. Matthias, M. M. Müller, W. Schaffner. 1989. Rapid detection of octamer binding proteins with “mini-extracts,” prepared from a small number of cells. Nucleic Acids Res. 17: 6419
    OpenUrlFREE Full Text
  22. ↵
    Jain, J., Z. Miner, A. Rao. 1993. Analysis of the pre-existing and nuclear forms of nuclear factor of activated T cells. J. Immunol. 151: 837
    OpenUrlAbstract
  23. ↵
    Aramburu, J., L. Azzoni, A. Rao, B. Perussia. 1995. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. J. Exp. Med. 182: 801
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Fruman, D. A., C. B. Klee, B. E. Bierer, S. J. Burakoff. 1992. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc. Natl. Acad. Sci. USA 89: 3686
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Burow, S., G. Valet. 1987. Flow-cytometric characterization of stimulation, free radical formation, peroxidase activity and phagocytosis of human granulocytes with 2,7-dichlorofluorescein (DCF). Eur. J. Cell Biol. 43: 128
    OpenUrlPubMed
  26. ↵
    Lahdenpohja, N., K. Savinainen, M. Hurme. 1998. Pre-exposure to oxidative stress decreases the nuclear factor-κ B-dependent transcription in T lymphocytes. J. Immunol. 160: 1354
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Holtz-Heppelmann, C. J., A. Algeciras, A. D. Badley, C. V. Paya. 1998. Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 273: 4416
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Schreiber, S. L., G. R. Crabtree. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13: 136
    OpenUrlCrossRefPubMed
  29. ↵
    Schreck, R., P. Rieber, P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10: 2247
    OpenUrlPubMed
  30. ↵
    Abate, C., L. Patel, F. J. Rauscher, III, T. Curran. 1990. Redox regulation of Fos and Jun DNA binding activity in vitro. Science 249: 1157
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Galter, D. S., S. Mihm, W. Dröge. 1994. Distinct effects of glutathione disulphide on the nuclear transcription factors κB and the activator protein-1. Eur. J. Biochem. 221: 639
    OpenUrlPubMed
  32. ↵
    Hayashi, T., Y. Ueno, T. Okamoto. 1993. Oxidoreductive regulation of nuclear factor κB. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268: 11380
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Beiqing, L., M. Chen, R. L. Whisler. 1996. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells. J. Immunol. 157: 160
    OpenUrlAbstract
  34. ↵
    Wang, X., V. C. Culotta, C. B. Klee. 1996. Superoxide dismutase protects calcineurin from inactivation. Nature 383: 434
    OpenUrlCrossRefPubMed
  35. ↵
    Furuke, K., H. Nakamura, T. Hori, S. Iwata, N. Maekawa, T. Inamoto, Y. Yamaoka, J. Yodoi. 1995. Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control. Int. Immunol. 7: 985
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Kissinger, C. R., H. E. Parge, D. R. Knighton, C. T. Lewis, L. A. Pelletier, A. Tempczyk, V. J. Kalish, K. D. Tucker, R. E. Showalter, E. W. Moomaw, et al 1995. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 378: 641
    OpenUrlCrossRefPubMed
  37. ↵
    Walker, P. R., P. Saas, P.-Y. Dietrich. 1997. Role of Fas ligand (CD95L) in immune escape the tumor cell strikes back. J. Immunol. 158: 4521
    OpenUrlAbstract
  38. ↵
    De Maria, R., R. Testi. 1998. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol. Today 19: 121
    OpenUrlCrossRefPubMed
  39. ↵
    Sakata, K.-m., A. Sakata, L. Kong, H. Dang, N. Talal. 1998. Role of Fas/FasL interaction in physiology and pathology: the good and the bad. Clin. Immunol. Immunopathol. 87: 1
    OpenUrlCrossRefPubMed
  40. ↵
    Halliwell, B., J. M. C. Gutteridge. 1990. Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol. 186: 1
    OpenUrlCrossRefPubMed
  41. ↵
    Delneste, Y., P. Jeannin, E. Sebille, J.-P. Aubry, J.-Y. Bonnefoy. 1996. Thiols prevent Fas (CD95)-mediated T cell apoptosis by down-regulating membrane Fas expression. Eur. J. Immunol. 26: 2981
    OpenUrlCrossRefPubMed
  42. ↵
    Suhara, T., K. Fukuo, T. Sugimoto, S. Morimoto, T. Nakahashi, S. Hata, M. Shimizu, T. Ogihara. 1998. Hydrogen peroxide induces up-regulation of Fas in human endothelial cells. J. Immunol. 160: 4042
    OpenUrlAbstract/FREE Full Text
  43. ↵
    Williams, M. S., P. A. Henkart. 1996. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol. 157: 2395
    OpenUrlAbstract
  44. ↵
    Bauer, M. K. A., M. Vogt, M. Los, J. Siegel, S. Wasselborg, K. Schulze-Osthoff. 1998. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J. Biol. Chem. 273: 8045
    OpenUrl
View Abstract
Back to top

In this issue

The Journal of Immunology: 162 (4)
The Journal of Immunology
Vol. 162, Issue 4
15 Feb 1999
Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section